Earnings per share

Amdocs Completes Acquisition of Openet to Accelerate the Pace of Taking the Communications Industry to the Cloud and Help Service Providers Differentiate in the 5G Era

Tuesday, August 11, 2020 - 9:05pm

With this acquisition, Amdocs stands ready to help services providers future-proof their business as they move into edge compute and 5G and accelerate their cloud journey and operational agility.

Key Points: 
  • With this acquisition, Amdocs stands ready to help services providers future-proof their business as they move into edge compute and 5G and accelerate their cloud journey and operational agility.
  • The impact on GAAP diluted EPS will not be known until after Amdocs completes the purchase price allocation.
  • Amdocs purpose is to enrich lives and progress society, using creativity and technology to build a better connected world.
  • Amdocs and its 25,000 employees partner with the leading players in the communications and media industry, enabling next-generation experiences in 85 countries.

The LGL Group Reports Second Quarter 2020 Results

Tuesday, August 11, 2020 - 9:00pm

The LGL Group, Inc. (NYSE American: LGL) (the Company or LGL), announced its financial results for the three and six months ended June 30, 2020.

Key Points: 
  • The LGL Group, Inc. (NYSE American: LGL) (the Company or LGL), announced its financial results for the three and six months ended June 30, 2020.
  • SECOND QUARTER RESULTS In 2020, LGLs second quarter revenues decreased $779,000, or 9.9%, to $7.1 million compared to $7.8 million for the corresponding quarter in 2019.
  • Adjusted EBITDA was $0.3 million in the second quarter of 2020 versus $1.0 million in the second quarter of 2019.
  • EARNINGS PER SHARE Diluted earnings per share from ongoing operations, during the second quarter were $0.05 per share in 2020 as compared to $0.19 per share in the second quarter of 2019.

ICU Medical, Inc. Announces Second Quarter 2020 Results

Monday, August 10, 2020 - 9:05pm

The non-GAAP financial measures should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP.

Key Points: 
  • The non-GAAP financial measures should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP.
  • The non-GAAP financial measures included in this press release are adjusted EBITDA and adjusted diluted earnings per share ("Adjusted Diluted EPS").
  • The value of stock options is determined using a complex formula that incorporates factors, such as market volatility, that are beyond our control.
  • Change in fair value of contingent earn-out: We exclude the impact of certain amounts recorded in connection with business combinations.

IBC Reports 2020 Earnings

Thursday, August 6, 2020 - 6:12pm

Net income for the six months ended June 30, 2020 was $76.3 million or $1.19 diluted earnings per common share ($1.19 per share basic), compared to $101.9 million or $1.55 diluted earnings per common share ($1.55 per share basic) for the same period of 2019, representing a decrease of 23.2 percent in diluted earnings per share and a decrease of 25.1 percent in net income.

Key Points: 
  • Net income for the six months ended June 30, 2020 was $76.3 million or $1.19 diluted earnings per common share ($1.19 per share basic), compared to $101.9 million or $1.55 diluted earnings per common share ($1.55 per share basic) for the same period of 2019, representing a decrease of 23.2 percent in diluted earnings per share and a decrease of 25.1 percent in net income.
  • Under the new model, our provision for credit losses increased to $22.0 million, net of tax for the six months ended June 30, 2020.
  • Net income was also impacted by the Federal Reserve Board action to rapidly decrease interest rates in March 2020.
  • In March 2020, the World Health Organization recognized the outbreak of the novel Coronavirus Disease 2019 (COVID-19) as a pandemic.

Saga Communications, Inc. Reports 2nd Quarter 2020 Results

Wednesday, August 5, 2020 - 2:00pm

The Company's balance sheet reflects $48.9 million in cash on hand as of June 30, 2020 and $47.5 million as of August 3, 2020.

Key Points: 
  • The Company's balance sheet reflects $48.9 million in cash on hand as of June 30, 2020 and $47.5 million as of August 3, 2020.
  • Diluted earnings per share were -$0.82 in the 2nd quarter of 2020.
  • Saga's 2020 2nd Quarter conference call will be on Wednesday, August 5, 2020 at 11:00 a.m. EDT.
  • Results may vary from those stated herein and Saga undertakes no obligation to update the information contained here.

Ahold Delhaize reports strong Q2 results that continue to be impacted by COVID-19

Wednesday, August 5, 2020 - 6:45am

Net sales were 19.1 billion, up 17.1%, or 15.9% at constant exchange rates

Key Points: 
  • Net sales were 19.1 billion, up 17.1%, or 15.9% at constant exchange rates
    Net consumer online sales grew 77.6% at constant exchange rates; Ahold Delhaize will reach 7 billion net consumer online sales goal in 2020, one year ahead of plan
    COVID-19-related costs were approximately 330 million in the first half of the year, and approximately 260 million in Q2, including safety measures and enhanced associate pay
    Diluted EPS was 0.65; diluted underlying EPS was 0.65, increasing 87.9%
    2020 outlook raised, with underlying EPS growth in the low-to-mid-20% range; free cash flow expected to be at least 1.7 billion, net of paying the majority of a tentative U.S. pension plan withdrawal agreement
    2020 interim dividend is 0.50, up 67% and based on 40% of first half 2020 underlying income per share1
    Zaandam, the Netherlands, August 5, 2020 Ahold Delhaize, one of the worlds largest food retail groups and a leader in both supermarkets and eCommerce, reports second quarter and half year results today.

Weyco Reports Second Quarter Sales And Earnings

Tuesday, August 4, 2020 - 9:05pm

As a result, the Company experienced significant sales volume losses during the quarter, which led to substantially lower second quarter earnings.

Key Points: 
  • As a result, the Company experienced significant sales volume losses during the quarter, which led to substantially lower second quarter earnings.
  • Net sales for the second quarter of 2020 were $16.7 million, down as compared to second quarter 2019 net sales of $60.5 million.
  • Diluted loss per share was $0.91 in the second quarter of 2020, compared to diluted earnings per share of $0.15 in the second quarter of 2019.
  • Gross earnings for the North American wholesale segment were 34.7% of net sales in the second quarter of 2020, compared to 35.1% of net sales in last year's second quarter.

QIAGEN Reports Full Results for Second Quarter and First Half Of 2020

Tuesday, August 4, 2020 - 9:06pm

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced full results of operations for the second quarter and first half of 2020, with net sales and adjusted earnings per share (EPS) in line with the preliminary results announced on July 9, 2020, and July 13, 2020.

Key Points: 
  • QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced full results of operations for the second quarter and first half of 2020, with net sales and adjusted earnings per share (EPS) in line with the preliminary results announced on July 9, 2020, and July 13, 2020.
  • Net sales for the second quarter of 2020 grew 16% over the second quarter of 2019 (+19% at constant exchange rates, or CER), and adjusted earnings per share were $0.56 CER (+70% CER) for the quarter.
  • The unprecedented demand for products used in coronavirus testing is driving QIAGENs performance in 2020.
  • Roland Sackers, Chief Financial Officer of QIAGEN N.V., added: QIAGENs swift response in scaling up production capacity for testing solutions to help fight the pandemic supported the double-digit sales growth in the second quarter.

CryoLife Reports Second Quarter 2020 Financial Results

Thursday, July 30, 2020 - 9:05pm

Given these achievements in the second quarter, we anticipate continued momentum in the second half of 2020 and are optimistic that we will have a strong 2021."

Key Points: 
  • Given these achievements in the second quarter, we anticipate continued momentum in the second half of 2020 and are optimistic that we will have a strong 2021."
  • Total revenues for the second quarter of 2020 were $53.8 million, reflecting a decrease of (24%), and (23%) on a non-GAAP constant currency basis, both compared to the second quarter of 2019.
  • Net loss for the second quarter of 2020 was ($3.7) million, or ($0.10) per fully diluted common share, compared to net income of $2.8 million, or $0.07 per fully diluted common share for the second quarter of 2019.
  • Non-GAAP net loss for the second quarter of 2020 was ($835,000), or ($0.02) per fully diluted common share, compared to non-GAAP net income of $4.1 million, or $0.11 per fully diluted common share for the second quarter of 2019.

NextGen Healthcare, Inc. Reports Fiscal 2021 First Quarter Results

Thursday, July 30, 2020 - 9:05pm

NextGen Healthcare, Inc. (Nasdaq: NXGN), the leading provider of ambulatory-focused healthcare technology solutions, announced today its fiscal 2021 first quarter ended June 30, 2020 operating results.

Key Points: 
  • NextGen Healthcare, Inc. (Nasdaq: NXGN), the leading provider of ambulatory-focused healthcare technology solutions, announced today its fiscal 2021 first quarter ended June 30, 2020 operating results.
  • On a GAAP basis, net loss for the fiscal 2021 first quarter was $0.8 million compared with net income of $1.2 million in the fiscal 2020 first quarter.
  • On a non-GAAP basis, fully diluted earnings per share for the fiscal 2021 first quarter was $0.21 versus $0.16 reported in the first quarter a year ago.
  • NextGen Healthcare will host a conference call to discuss its fiscal 2021 first quarter operating results on Thursday, July 30, 2019 at 5:00 PM ET (2:00 PM PT).